The number of spine synapses in CA1 stratum radiatum (CA1sr), CA3 stratum lucidum and radiatum (CA3sl/sr), dentate gyrus stratum moleculare (DGsm), and layer II/III of PFC of vehicle-treated (Control), estradiol benzoate-treated (EB), BPA-treated (BPA), and EB+BPA-treated (EB+BPA) monkeys. One-way ANOVA revealed significant treatment effects in all four brain regions examined (CA1sr: F3,8 = 354.2, P < .001; CA3sl/sr: F3,8 = 151.8, P < .001; DGsm: F3,8 = 330.5, P < .001; PFC: F3,8 = 60.7, P < .001). Asterisks above the bars indicate significant differences versus the corresponding sampling area of vehicle-treated controls (Tukey-Kramer test; P < .05). Spine synapse numbers in the BPA and the EB+BPA groups were not significantly different from those of controls.